Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.
Nakou ES, Simantirakis EN, Kallergis EM, Nakos KS, Vardas PE.
Europace. 2017 May 1;19(5):705-711. doi: 10.1093/europace/euw317.
Downgrade from CRT-D to CRT-P at time of generator replacement: a true clinical conundrum or just an academic debate?
Clarke JD, Friedman DJ.
J Interv Card Electrophysiol. 2023 Sep;66(6):1315-1316. doi: 10.1007/s10840-023-01506-y. Epub 2023 Feb 16.
Clinical predictors of pocket hematoma after cardiac device implantation and replacement.
Ferretto S, Mattesi G, Migliore F, Susana A, De Lazzari M, Iliceto S, Leoni L, Bertaglia E.
J Cardiovasc Med (Hagerstown). 2020 Feb;21(2):123-127. doi: 10.2459/JCM.0000000000000914.
Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Narducci ML, Biffi M, Ammendola E, Vado A, Campana A, Potenza DR, Iori M, Zanon F, Zacà V, Zoni Berisso M, Bertini M, Lissoni F, Bandini A, Malacrida M, Crea F.
Europace. 2018 Sep 1;20(9):1475-1483. doi: 10.1093/europace/eux323.
Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.
Ellis CR, Dickerman DI, Orton JM, Hassan S, Good ED, Okabe T, Andriulli JA, Quan KJ, Greenspon AJ.
Pacing Clin Electrophysiol. 2016 Jul;39(7):658-68. doi: 10.1111/pace.12831. Epub 2016 Mar 11.
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care.
Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund LH, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Nielsen JC, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C.
Europace. 2021 Aug 6;23(8):1324-1342. doi: 10.1093/europace/euaa411.
Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients.
Kirchner J, Gerçek M, Sciacca V, Reil JC, Guckel D, Potratz M, Omran H, Friedrichs K, Eitz T, Bleiziffer S, Schramm R, Imnadze G, Sohns C, Gummert J, Rudolph V, Rudolph TK, Sommer P, Fink T.
Clin Res Cardiol. 2024 May 2. doi: 10.1007/s00392-024-02450-1. Online ahead of print.
European experience with a first totally leadless cardiac resynchronization therapy pacemaker system.
Carabelli A, Jabeur M, Jacon P, Rinaldi CA, Leclercq C, Rovaris G, Arnold M, Venier S, Neuzil P, Defaye P.
Europace. 2021 May 21;23(5):740-747. doi: 10.1093/europace/euaa342.
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M.
Europace. 2018 Dec 1;20(12):1882-1897. doi: 10.1093/europace/euy066.
A devices' game of thrones: cardiac resynchronization therapy vs. pacemaker.
Moura-Ferreira S, Gonçalves H, Oliveira M, Primo J, Fonseca P, Ribeiro J, Santos E, Pelicano N, Martins D, Gama V.
Europace. 2017 Dec 1;19(12):2042-2046. doi: 10.1093/europace/eux081.
